Ambayya Angeli, Sahibon Santina, Yang Thoo Wei, Zhang Qian-Yun, Hassan Rosline, Sathar Jameela
Haematology Department, Hospital Ampang, Ampang 68000, Selangor, Malaysia.
Department Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 15200, Kelantan, Malaysia.
Diagnostics (Basel). 2021 Nov 22;11(11):2163. doi: 10.3390/diagnostics11112163.
Thalassemia is one of the major inherited haematological disorders in the Southeast Asia region. This study explored the potential utility of red blood cell (RBC) parameters and reticulocyte cell population data (CPD) parameters in the differential diagnosis of α and β-thalassaemia traits as a rapid and cost-effective tool for screening of thalassemia traits. In this study, a total of 1597 subjects (1394 apparently healthy subjects, 155 subjects with α-thalassaemia trait, and 48 subjects with β-thalassaemia trait) were accrued. The parameters studied were the RBC parameters and reticulocyte CPD parameters derived from Unicel DxH800. A novel algorithm named αβ-algorithm was developed: (MN-LMALS-RET × RDW) - MCH) to discriminate α from β-thalassaemia trait with a cut-off value of 1742.5 [AUC = 0.966, sensitivity = 92%, specificity = 90%, 95% CI = 0.94-0.99]. Two prospective studies were carried: an in-house cohort to assess the specificity of this algorithm in 310 samples comprising various RBC disorders and in an interlaboratory cohort of 65 α-thalassemia trait, and 30 β-thalassaemia trait subjects to assess the reproducibility of the findings. We propose the αβ-algorithm to serve as a rapid, inexpensive surrogate evaluation tool of α and β-thalassaemia in the population screening of thalassemia traits in geographic regions with a high burden of these inherited blood disorders.
地中海贫血是东南亚地区主要的遗传性血液疾病之一。本研究探讨了红细胞(RBC)参数和网织红细胞细胞群数据(CPD)参数在鉴别α和β地中海贫血特征中的潜在效用,作为一种快速且经济高效的地中海贫血特征筛查工具。在本研究中,共纳入了1597名受试者(1394名明显健康的受试者、155名α地中海贫血特征受试者和48名β地中海贫血特征受试者)。所研究的参数是来自Unicel DxH800的RBC参数和网织红细胞CPD参数。开发了一种名为αβ算法的新算法:(MN-LMALS-RET×RDW)-MCH,以区分α和β地中海贫血特征,截断值为1742.5 [AUC = 0.966,敏感性 = 92%,特异性 = 90%,95% CI = 0.94 - 0.99]。进行了两项前瞻性研究:一项内部队列研究,以评估该算法在310个包含各种RBC疾病的样本中的特异性;另一项实验室间队列研究,纳入65名α地中海贫血特征受试者和30名β地中海贫血特征受试者,以评估研究结果的可重复性。我们建议αβ算法可作为一种快速、廉价的替代评估工具,用于在这些遗传性血液疾病负担较高的地理区域进行地中海贫血特征的人群筛查,以鉴别α和β地中海贫血。